The studys most important finding was the average 5.0 kg drop in body weight that was seen with semaglutide, mostly due to a reduction in body fat mass
An update on the global disparities in kidney disease burden and care across world countries and regions
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications that mimic the action of endogenous GLP-1, an incretin hormone secreted by intestinal L-cells in response to nutrient intake
Apr 17, 2026 Learn how to store reconstituted peptides safely
If prescribed, the provider will explain how to properly inject semaglutide under the skin of the abdomen, thigh, or upper arm using a prefilled pen device
This hormone glucagon-like peptide-1 (GLP-1) triggers insulin release, which lowers blood sugar levels by helping usher sugar into cells